‘I thought my brain would explode’: How Ella’s family hike led to painful disease
The article mentions a vaccine available in Australia that is recommended for travelers going to tropical regions. It highlights the importance of vaccination for those planning trips to such areas, but does not provide specific details about the vaccine, its efficacy, or any particular incidents related to its use.
Ella Stiebel endured days of excruciating pain after contracting dengue fever during a family trip to Bali. The illness left her bedridden in a hotel room, unable to eat, walk or tolerate bright lights. She described experiencing a panic attack before leaving Bali, fearing her brain would explode due to the altitude on the flight home. Stiebel, a student social worker from Melbourne, caught the virus along with her father during the trip. A blood test confirmed the diagnosis after two-and-a-half weeks of symptoms. Dengue, a mosquito-borne viral infection, is becoming increasingly common in tropical tourist destinations. It has also prompted a state of emergency in parts of Florida. The Australian Technical Advisory Group on Immunisation recently recommended the use of the Qdenga vaccine for travelers, particularly those who have previously contracted the disease. This vaccine offers protection against all four strains of the virus. Most individuals recover within a week, but some develop severe forms requiring hospitalization, leading to internal bleeding and potentially death. Recontracting dengue can severely disrupt the immune system, according to Dr. Deb Mills, medical director of the Travel Medicine Alliance. She warned that people can suffer from bleeding into their skin and dangerously low blood pressure, emphasizing the severity of the condition. Approximately three-quarters of dengue cases are asymptomatic, making it difficult for people to know they have been infected. Updated guidance from ATAGI highlights that half of Australia's top ten most-visited locations, Indonesia, Thailand, India, Vietnam and Fiji, experience regular or ongoing dengue transmission. The dengue mosquito thrives in urban environments, preferring stagnant water found in items such as pot plant saucers. Unlike malaria, which typically bites at night, dengue mosquitoes bite during the day when tourists are active. This makes prevention challenging despite measures like insect repellent, long sleeves and mosquito nets. Symptoms of dengue include severe pain behind the eyes, high fever, chills, and intense headaches and muscle and joint pain. While many cases are mild or asymptomatic, others can experience prolonged effects, such as hair loss. In Australia, there were 2,641 reported dengue cases in the twelve months ending April 2025, nearly all acquired abroad. Global dengue cases have surged from 505,430 in 2000 to at least 14.6 million in 2024, attributed to rising temperatures, increased humidity, urbanization and the spread of mosquitoes. Studies suggest one percent of visitors to tropical regions are exposed to dengue. Many who have suffered from the illness avoid revisiting these areas due to fears of a more severe recurrence. The availability of the Qdenga vaccine could change this landscape, though its previous high cost, $500 per dose, made it inaccessible for many. Increased supply is anticipated to reduce costs following ATAGI's updated recommendations. Despite preventive efforts, both Stiebel and her father fell ill, highlighting the difficulty of avoiding the virus.
Go to the primary sources (1)
The official sources this coverage is built on. Read them directly to bypass framing.
The article mentions a vaccine available in Australia that is recommended for travelers going to tropical regions. It highlights the importance of vaccination for those planning trips to such areas, but does not provide specific details about the vaccine, its efficacy, or any particular incidents related to its use.
Bias read (Center): The article discusses a health-related recommendation without taking a political stance. It focuses on medical advice for travelers and does not involve contentious political issues.
Why factuality: no official source document/info detected
Why objectivity (75): Like the first article, this piece uses a narrative style that highlights the emotional impact of the illness. This approach can be seen as subjective, as it prioritizes storytelling over purely factual reporting.
The Sydney Morning HeraldIndependentCenterFactual: no official source document/info detectedObjective 75
The article mentions a vaccine available in Australia that is recommended for travelers going to tropical regions. It highlights the importance of vaccination for those planning trips to such areas, but does not provide specific details about the vaccine, its efficacy, or any particular incidents related to its use.
Bias read (Center): The article discusses a medical recommendation without taking a political stance. It focuses on health advice for travelers and does not involve contentious political issues, making it apolitical in nature.
Why factuality: no official source document/info detected
Why objectivity (75): The tone of both articles is empathetic and narrative-driven, focusing on the personal experience of the family. While this adds emotional depth, it may introduce bias by emphasizing the distressing aspects of the illness over more objective medical reporting.
How each side covered it
The same event, grouped by the political lean of the outlets covering it.
progressive
center
conservative
★
How each side covered it
Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.